-
ETON Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Eton Pharmaceuticals (ETON)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 20.26 mm | 20.26 mm | 20.26 mm | 20.26 mm | 20.26 mm | 20.26 mm |
Cash burn (monthly) | (no burn) | 150.75 k | (no burn) | 441.50 k | (no burn) | (no burn) |
Cash used (since last report) | n/a | 765.97 k | n/a | 2.24 mm | n/a | n/a |
Cash remaining | n/a | 19.50 mm | n/a | 18.02 mm | n/a | n/a |
Runway (months of cash) | n/a | 129.3 | n/a | 40.8 | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 23 |
Opened positions | 5 |
Closed positions | 26 |
Increased positions | 3 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 16.35 bn |
Total shares | 2.94 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 1.03 mm | $6.17 bn |
Acuitas Investments | 579.96 k | $3.48 bn |
BlackRock | 284.86 k | $1.71 bn |
Geode Capital Management | 272.70 k | $1.64 bn |
EAM Investors | 128.28 k | $769.66 mm |
Thompson Siegel & Walmsley | 115.03 k | $690.00 k |
Acadian Asset Management | 105.95 k | $634.00 k |
Renaissance Technologies | 83.40 k | $500.40 mm |
BK The Bank of New York Mellon Corporation | 74.49 k | $446.95 mm |
Connor, Clark & Lunn Investment Management | 65.01 k | $390.08 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 25 | David Krempa | RSU Common Stock | Grant | Acquire A | No | No | 0 | 25,876 | 0.00 | 25,876 |
3 Jan 25 | David Krempa | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 13 | 38,621 | 502.07 k | 38,621 |
3 Jan 25 | Maier Paul V | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 13 | 25,000 | 325.00 k | 25,000 |
3 Jan 25 | Jennifer McKie Adams | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 13 | 25,000 | 325.00 k | 25,000 |
3 Jan 25 | Riedel Norbert G | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 13 | 25,000 | 325.00 k | 25,000 |
3 Jan 25 | Riedel Norbert G | Common Stock | Option exercise | Acquire M | No | No | 3.47 | 25,000 | 86.75 k | 162,145 |
3 Jan 25 | Riedel Norbert G | Common Stock | Option exercise | Acquire M | No | No | 3.78 | 50,000 | 189.00 k | 137,145 |
3 Jan 25 | Riedel Norbert G | Common Stock | Option exercise | Acquire M | No | No | 3.58 | 27,400 | 98.09 k | 87,145 |
3 Jan 25 | Riedel Norbert G | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.47 | 25,000 | 86.75 k | 0 |
3 Jan 25 | Riedel Norbert G | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.78 | 50,000 | 189.00 k | 0 |